Visceral-Fat Reduction
FDA-approved tesamorelin is indicated to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. A provider determines whether tesamorelin is appropriate for a patient’s specific clinical circumstances.
PEPTIDES & LONGEVITY
Tesamorelin
INJECTION
Tesamorelin is a growth hormone-releasing factor analog that encourages the body's own pituitary gland to release growth hormone. It may be considered by a licensed medical provider for eligible adults with specific body-composition, metabolic, or clinically appropriate treatment goals.
$229/month
All-inclusive pricing
All-inclusive pricing
Provider consultation, medication if prescribed, standard shipping, and applicable taxes are included. No insurance required.
Start AssessmentGet Started
Prescription treatment requires an online medical evaluation. A licensed provider determines whether treatment is clinically appropriate. Treatment is not guaranteed.
Targeted support for body composition and metabolic wellness.
Tesamorelin is a growth hormone-releasing factor analog that encourages the body’s own pituitary gland to release growth hormone. It may be considered by a licensed medical provider for eligible adults with specific body-composition, metabolic, or clinically appropriate treatment goals.
Your health history, current medications, laboratory information when required, and individual goals are evaluated before treatment is prescribed.
- Body-Composition Support
- Growth Hormone Pathway
- Metabolic Wellness
- Provider-Guided Care
MEET TESAMORELIN
Working with your body’s natural signaling pathway.
Tesamorelin is a synthetic analog of growth hormone-releasing factor, also called growth hormone-releasing hormone. Rather than supplying growth hormone directly, tesamorelin signals the pituitary gland to increase the body’s natural production and release of growth hormone.
This process can increase insulin-like growth factor 1, commonly called IGF-1, which participates in growth hormone signaling, body-composition regulation, and metabolic processes.
Tesamorelin is not a general-purpose weight-loss medication. Treatment decisions must be based on a licensed provider’s evaluation of the individual patient, the intended use, potential benefits, and potential risks.
WHY TESAMORELIN MAY BE CONSIDERED
A targeted approach to clinically appropriate body-composition goals.
When prescribed for an appropriate patient, tesamorelin works through the body’s growth hormone-releasing pathway and may support specific body-composition and metabolic objectives.
Body-Composition Support
Tesamorelin may support changes in abdominal-fat distribution and body composition for appropriately selected patients without functioning as a conventional weight-loss medication.
Natural Growth Hormone Signaling
Stimulates the pituitary gland’s growth hormone-releasing pathway rather than supplying growth hormone directly.
Metabolic-Health Monitoring
Treatment may be incorporated into a personalized plan that considers body composition, glucose health, IGF-1 levels, and other clinically relevant factors.
Personalized Medical Oversight
Provider review helps determine whether the potential benefits of treatment are appropriate in relation to each patient’s medical history and risks.
Tesamorelin is not indicated for general weight-loss management and may have a weight-neutral effect. Treatment outcomes vary and are not guaranteed.
IS TESAMORELIN RIGHT FOR YOU?
Treatment begins with the right clinical context.
Tesamorelin is a specialized prescription treatment rather than a general wellness supplement. A licensed provider must evaluate the reason for treatment, medical history, pituitary function, cancer history, glucose health, pregnancy status, current medications, and any required laboratory results.
- Seeking clinician-guided body-composition care
- Interested in a growth hormone-releasing approach
- Prepared for appropriate clinical monitoring
- Comfortable following a prescribed injectable plan
Not everyone who completes an assessment will qualify. Your provider determines whether Tesamorelin is medically appropriate and whether another treatment may better fit your needs.
THE SCIENCE
Supporting the growth hormone–IGF-1 pathway.
Tesamorelin mimics the action of naturally occurring growth hormone-releasing hormone. It binds to receptors in the pituitary gland and stimulates the pulsatile release of growth hormone. This can subsequently increase circulating IGF-1.
- 01
Tesamorelin
Growth hormone-releasing signal
- 02
Pituitary Response
Stimulates natural growth hormone release
- 03
IGF-1 Pathway
Participates in body-composition and metabolic processes
The effects and appropriateness of this pathway depend on the patient’s health status, clinical reason for treatment, response, and monitoring. Tesamorelin should not be presented as equivalent to conventional weight-loss medication or direct growth hormone therapy.
How it works
Three steps to personalized care.
Simple online care, reviewed by licensed medical providers.
- 01
Tell us about yourself
Complete a secure online health assessment so your provider can understand your goals, symptoms, and medical history.
- 02
Your provider reviews your care
A licensed medical provider evaluates your information and determines which treatment options may be clinically appropriate.
- 03
Begin your personalized plan
If prescribed, your treatment is delivered discreetly, with ongoing support and follow-up as needed.
What’s included
- Private online health assessment
- Licensed-provider consultation and medical review
- Medication if prescribed
- Ongoing treatment support
- Standard shipping
- Applicable taxes
- No separate membership fee
- Required injection supplies when provided with the prescription
Important Safety Information
- Do not use Tesamorelin if you are pregnant or have had a serious allergic reaction to Tesamorelin or an ingredient in the dispensed medication.
- Tell your provider about any malignancy or hypothalamic-pituitary condition and all medications you take.
- Common side effects may include injection-site reactions, swelling, joint or muscle discomfort, and fluid retention.
Frequently asked questions
Is Tesamorelin a weight-loss medication?
No. Tesamorelin is not indicated for general weight-loss management and may have a weight-neutral effect. A provider evaluates its potential use based on the patient’s specific clinical circumstances.
Is Tesamorelin the same as growth hormone?
No. Tesamorelin is a growth hormone-releasing factor analog. It signals the pituitary gland to increase the body’s natural release of growth hormone rather than directly supplying growth hormone.
Does Tesamorelin require a prescription?
Yes. A licensed medical provider must evaluate your health information and determine whether treatment is medically appropriate.
Will I need laboratory monitoring?
Your provider determines whether laboratory testing or ongoing monitoring is needed based on your health history, treatment plan, IGF-1 levels, glucose health, and response to treatment.
Is treatment guaranteed?
No. Prescription approval and treatment outcomes are not guaranteed. A licensed provider determines eligibility after reviewing your medical information.
Explore related treatments.
Injection
Sermorelin
A provider-guided peptide treatment that stimulates the body’s natural growth hormone-releasing pathway and may support sleep, recovery, energy, and body-composition goals.
Injection
BPC-157
A provider-guided injectable peptide option for adults exploring additional support for recovery, mobility, and tissue health.
Injection
Klow
A four-peptide injectable formulation explored for comprehensive support across recovery, tissue wellness, skin vitality, and whole-body resilience.
Ready to explore a more targeted approach?
Complete a secure online assessment to help a licensed medical provider determine whether Tesamorelin may be appropriate for your clinical needs and treatment goals.